Global Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Research Report 2022

Publisher Name :
Date: 21-Jun-2022
No. of pages: 96
Inquire Before Buying

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type

- Dominant Optic Atrophy

- Recessive Optic Atrophy

Segment by Application

- Hospitals

- Eye Clinics

- Medical Research Institute

- Other

By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- - Philippines

- - Vietnam

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - U.A.E

By Company

- Alkeus Pharmaceuticals

- Amgen

- Biovista

- Editas Medicine

- GenSight Biologics

- Ixchel Pharma

- Khondrion

- Mitotech

- ProQR Therapeutics

- Sanofi

- Spark Therapeutics

- Stealth BioTherapeutics

- Usher Syndrome

Global Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Research Report 2022

Table of Contents
1 Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Overview
1.1 Product Overview and Scope of Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy)
1.2 Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Segment by Type
1.2.1 Global Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Dominant Optic Atrophy
1.2.3 Recessive Optic Atrophy
1.3 Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Segment by Application
1.3.1 Global Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Comparison by Application: (2022-2028)
1.3.2 Hospitals
1.3.3 Eye Clinics
1.3.4 Medical Research Institute
1.3.5 Other
1.4 Global Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size Estimates and Forecasts
1.4.1 Global Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue 2017-2028
1.4.2 Global Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales 2017-2028
1.4.3 Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size by Region: 2017 Versus 2021 Versus 2028
2 Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Competition by Manufacturers
2.1 Global Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Manufacturers (2017-2022)
2.2 Global Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Manufacturing Sites, Area Served, Product Type
2.5 Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Competitive Situation and Trends
2.5.1 Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Players Market Share by Revenue
2.5.3 Global Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Retrospective Market Scenario by Region
3.1 Global Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Facts & Figures by Country
3.3.1 North America Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Country
3.3.2 North America Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Facts & Figures by Country
3.4.1 Europe Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Country
3.4.2 Europe Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Facts & Figures by Region
3.5.1 Asia Pacific Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Region
3.5.2 Asia Pacific Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Facts & Figures by Country
3.6.1 Latin America Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Country
3.6.2 Latin America Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Facts & Figures by Country
3.7.1 Middle East and Africa Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Country
3.7.2 Middle East and Africa Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Historic Market Analysis by Type
4.1 Global Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Type (2017-2022)
4.2 Global Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share by Type (2017-2022)
4.3 Global Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Price by Type (2017-2022)
5 Global Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Historic Market Analysis by Application
5.1 Global Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Application (2017-2022)
5.2 Global Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share by Application (2017-2022)
5.3 Global Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Price by Application (2017-2022)
6 Key Companies Profiled
6.1 Alkeus Pharmaceuticals
6.1.1 Alkeus Pharmaceuticals Corporation Information
6.1.2 Alkeus Pharmaceuticals Description and Business Overview
6.1.3 Alkeus Pharmaceuticals Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, Revenue and Gross Margin (2017-2022)
6.1.4 Alkeus Pharmaceuticals Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Portfolio
6.1.5 Alkeus Pharmaceuticals Recent Developments/Updates
6.2 Amgen
6.2.1 Amgen Corporation Information
6.2.2 Amgen Description and Business Overview
6.2.3 Amgen Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, Revenue and Gross Margin (2017-2022)
6.2.4 Amgen Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Portfolio
6.2.5 Amgen Recent Developments/Updates
6.3 Biovista
6.3.1 Biovista Corporation Information
6.3.2 Biovista Description and Business Overview
6.3.3 Biovista Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Biovista Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Portfolio
6.3.5 Biovista Recent Developments/Updates
6.4 Editas Medicine
6.4.1 Editas Medicine Corporation Information
6.4.2 Editas Medicine Description and Business Overview
6.4.3 Editas Medicine Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Editas Medicine Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Portfolio
6.4.5 Editas Medicine Recent Developments/Updates
6.5 GenSight Biologics
6.5.1 GenSight Biologics Corporation Information
6.5.2 GenSight Biologics Description and Business Overview
6.5.3 GenSight Biologics Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, Revenue and Gross Margin (2017-2022)
6.5.4 GenSight Biologics Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Portfolio
6.5.5 GenSight Biologics Recent Developments/Updates
6.6 Ixchel Pharma
6.6.1 Ixchel Pharma Corporation Information
6.6.2 Ixchel Pharma Description and Business Overview
6.6.3 Ixchel Pharma Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Ixchel Pharma Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Portfolio
6.6.5 Ixchel Pharma Recent Developments/Updates
6.7 Khondrion
6.6.1 Khondrion Corporation Information
6.6.2 Khondrion Description and Business Overview
6.6.3 Khondrion Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Khondrion Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Portfolio
6.7.5 Khondrion Recent Developments/Updates
6.8 Mitotech
6.8.1 Mitotech Corporation Information
6.8.2 Mitotech Description and Business Overview
6.8.3 Mitotech Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, Revenue and Gross Margin (2017-2022)
6.8.4 Mitotech Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Portfolio
6.8.5 Mitotech Recent Developments/Updates
6.9 ProQR Therapeutics
6.9.1 ProQR Therapeutics Corporation Information
6.9.2 ProQR Therapeutics Description and Business Overview
6.9.3 ProQR Therapeutics Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, Revenue and Gross Margin (2017-2022)
6.9.4 ProQR Therapeutics Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Portfolio
6.9.5 ProQR Therapeutics Recent Developments/Updates
6.10 Sanofi
6.10.1 Sanofi Corporation Information
6.10.2 Sanofi Description and Business Overview
6.10.3 Sanofi Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, Revenue and Gross Margin (2017-2022)
6.10.4 Sanofi Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Portfolio
6.10.5 Sanofi Recent Developments/Updates
6.11 Spark Therapeutics
6.11.1 Spark Therapeutics Corporation Information
6.11.2 Spark Therapeutics Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Description and Business Overview
6.11.3 Spark Therapeutics Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, Revenue and Gross Margin (2017-2022)
6.11.4 Spark Therapeutics Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Portfolio
6.11.5 Spark Therapeutics Recent Developments/Updates
6.12 Stealth BioTherapeutics
6.12.1 Stealth BioTherapeutics Corporation Information
6.12.2 Stealth BioTherapeutics Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Description and Business Overview
6.12.3 Stealth BioTherapeutics Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, Revenue and Gross Margin (2017-2022)
6.12.4 Stealth BioTherapeutics Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Portfolio
6.12.5 Stealth BioTherapeutics Recent Developments/Updates
6.13 Usher Syndrome
6.13.1 Usher Syndrome Corporation Information
6.13.2 Usher Syndrome Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Description and Business Overview
6.13.3 Usher Syndrome Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, Revenue and Gross Margin (2017-2022)
6.13.4 Usher Syndrome Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Portfolio
6.13.5 Usher Syndrome Recent Developments/Updates
7 Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Manufacturing Cost Analysis
7.1 Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy)
7.4 Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Distributors List
8.3 Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Customers
9 Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Dynamics
9.1 Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Industry Trends
9.2 Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Drivers
9.3 Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Challenges
9.4 Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Restraints
10 Global Market Forecast
10.1 Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) by Type (2023-2028)
10.2 Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) by Application (2023-2028)
10.3 Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Growth Rate Comparison by Type (2022-2028) & (K Pcs) & (US$ Million)
Table 2. Global Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Growth Rate Comparison by Application (2022-2028) & (K Pcs) & (US$ Million)
Table 3. Global Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
Table 4. Global Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Competitive Situation by Manufacturers in 2021
Table 5. Global Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs) of Key Manufacturers (2017-2022)
Table 6. Global Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue (US$ Million) by Manufacturers (2017-2022)
Table 8. Global Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Share by Manufacturers (2017-2022)
Table 9. Global Market Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Average Price (USD/Piece) of Key Manufacturers (2017-2022)
Table 10. Manufacturers Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Manufacturing Sites and Area Served
Table 11. Manufacturers Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) as of 2021)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Region (2017-2022) & (K Pcs)
Table 16. Global Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Region (2017-2022)
Table 17. Global Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Region (2017-2022) & (US$ Million)
Table 18. Global Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share by Region (2017-2022)
Table 19. North America Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Country (2017-2022) & (K Pcs)
Table 20. North America Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Country (2017-2022)
Table 21. North America Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Country (2017-2022) & (US$ Million)
Table 22. North America Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share by Country (2017-2022)
Table 23. Europe Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Country (2017-2022) & (K Pcs)
Table 24. Europe Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Country (2017-2022)
Table 25. Europe Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Country (2017-2022) & (US$ Million)
Table 26. Europe Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share by Country (2017-2022)
Table 27. Asia Pacific Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Region (2017-2022) & (K Pcs)
Table 28. Asia Pacific Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Region (2017-2022)
Table 29. Asia Pacific Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Region (2017-2022) & (US$ Million)
Table 30. Asia Pacific Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share by Region (2017-2022)
Table 31. Latin America Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Country (2017-2022) & (K Pcs)
Table 32. Latin America Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Country (2017-2022)
Table 33. Latin America Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Country (2017-2022) & (US$ Million)
Table 34. Latin America Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share by Country (2017-2022)
Table 35. Middle East and Africa Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Country (2017-2022) & (K Pcs)
Table 36. Middle East and Africa Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Country (2017-2022)
Table 37. Middle East and Africa Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Country (2017-2022) & (US$ Million)
Table 38. Middle East and Africa Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share by Country (2017-2022)
Table 39. Global Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Type (2017-2022) & (K Pcs)
Table 40. Global Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Type (2017-2022)
Table 41. Global Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Type (2017-2022) & (US$ Million)
Table 42. Global Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Share by Type (2017-2022)
Table 43. Global Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Price by Type (2017-2022) & (USD/Piece)
Table 44. Global Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs) by Application (2017-2022)
Table 45. Global Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Application (2017-2022)
Table 46. Global Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Share by Application (2017-2022)
Table 48. Global Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Price by Application (2017-2022) & (USD/Piece)
Table 49. Alkeus Pharmaceuticals Corporation Information
Table 50. Alkeus Pharmaceuticals Description and Business Overview
Table 51. Alkeus Pharmaceuticals Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2017-2022)
Table 52. Alkeus Pharmaceuticals Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product
Table 53. Alkeus Pharmaceuticals Recent Developments/Updates
Table 54. Amgen Corporation Information
Table 55. Amgen Description and Business Overview
Table 56. Amgen Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2017-2022)
Table 57. Amgen Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product
Table 58. Amgen Recent Developments/Updates
Table 59. Biovista Corporation Information
Table 60. Biovista Description and Business Overview
Table 61. Biovista Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2017-2022)
Table 62. Biovista Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product
Table 63. Biovista Recent Developments/Updates
Table 64. Editas Medicine Corporation Information
Table 65. Editas Medicine Description and Business Overview
Table 66. Editas Medicine Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2017-2022)
Table 67. Editas Medicine Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product
Table 68. Editas Medicine Recent Developments/Updates
Table 69. GenSight Biologics Corporation Information
Table 70. GenSight Biologics Description and Business Overview
Table 71. GenSight Biologics Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2017-2022)
Table 72. GenSight Biologics Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product
Table 73. GenSight Biologics Recent Developments/Updates
Table 74. Ixchel Pharma Corporation Information
Table 75. Ixchel Pharma Description and Business Overview
Table 76. Ixchel Pharma Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2017-2022)
Table 77. Ixchel Pharma Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product
Table 78. Ixchel Pharma Recent Developments/Updates
Table 79. Khondrion Corporation Information
Table 80. Khondrion Description and Business Overview
Table 81. Khondrion Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2017-2022)
Table 82. Khondrion Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product
Table 83. Khondrion Recent Developments/Updates
Table 84. Mitotech Corporation Information
Table 85. Mitotech Description and Business Overview
Table 86. Mitotech Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2017-2022)
Table 87. Mitotech Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product
Table 88. Mitotech Recent Developments/Updates
Table 89. ProQR Therapeutics Corporation Information
Table 90. ProQR Therapeutics Description and Business Overview
Table 91. ProQR Therapeutics Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2017-2022)
Table 92. ProQR Therapeutics Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product
Table 93. ProQR Therapeutics Recent Developments/Updates
Table 94. Sanofi Corporation Information
Table 95. Sanofi Description and Business Overview
Table 96. Sanofi Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2017-2022)
Table 97. Sanofi Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product
Table 98. Sanofi Recent Developments/Updates
Table 99. Spark Therapeutics Corporation Information
Table 100. Spark Therapeutics Description and Business Overview
Table 101. Spark Therapeutics Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2017-2022)
Table 102. Spark Therapeutics Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product
Table 103. Spark Therapeutics Recent Developments/Updates
Table 104. Stealth BioTherapeutics Corporation Information
Table 105. Stealth BioTherapeutics Description and Business Overview
Table 106. Stealth BioTherapeutics Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2017-2022)
Table 107. Stealth BioTherapeutics Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product
Table 108. Stealth BioTherapeutics Recent Developments/Updates
Table 109. Usher Syndrome Corporation Information
Table 110. Usher Syndrome Description and Business Overview
Table 111. Usher Syndrome Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2017-2022)
Table 112. Usher Syndrome Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product
Table 113. Usher Syndrome Recent Developments/Updates
Table 114. Production Base and Market Concentration Rate of Raw Material
Table 115. Key Suppliers of Raw Materials
Table 116. Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Distributors List
Table 117. Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Customers List
Table 118. Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Trends
Table 119. Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Drivers
Table 120. Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Challenges
Table 121. Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Restraints
Table 122. Global Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Forecast by Type (2023-2028) & (K Pcs)
Table 123. Global Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share Forecast by Type (2023-2028)
Table 124. Global Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 125. Global Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share Forecast by Type (2023-2028)
Table 126. Global Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Forecast by Application (2023-2028) & (K Pcs)
Table 127. Global Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share Forecast by Application (2023-2028)
Table 128. Global Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 129. Global Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share Forecast by Application (2023-2028)
Table 130. Global Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Forecast by Region (2023-2028) & (K Pcs)
Table 131. Global Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share Forecast by Region (2023-2028)
Table 132. Global Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 133. Global Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share Forecast by Region (2023-2028)
Table 134. Research Programs/Design for This Report
Table 135. Key Data Information from Secondary Sources
Table 136. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy)
Figure 2. Global Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Share by Type in 2021 & 2028
Figure 3. Dominant Optic Atrophy Product Picture
Figure 4. Recessive Optic Atrophy Product Picture
Figure 5. Global Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Share by Application in 2021 & 2028
Figure 6. Hospitals
Figure 7. Eye Clinics
Figure 8. Medical Research Institute
Figure 9. Other
Figure 10. Global Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size (2017-2028) & (US$ Million)
Figure 12. Global Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (2017-2028) & (K Pcs)
Figure 13. Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Share by Manufacturers in 2021
Figure 14. Global Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Share by Manufacturers in 2021
Figure 15. The Global 5 and 10 Largest Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Players: Market Share by Revenue in 2021
Figure 16. Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 17. Global Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Region (2017-2022)
Figure 18. Global Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Region in 2021
Figure 19. Global Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share by Region (2017-2022)
Figure 20. Global Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share by Region in 2021
Figure 21. U.S. Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 22. Canada Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 23. Germany Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 24. France Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 25. U.K. Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 26. Italy Leber's Hereditary Optic Neuropathy (LHON
  • Global Benzocaine Drugs Market Research Report 2022
    Published: 21-Jun-2022        Price: US 2900 Onwards        Pages: 92
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - 15% Benzocaine Gel - 20% Benzocaine Gel - 15% Benzocaine Spray - 20% Benzocaine Spray - Benzo......
  • Global Medical Grade Honey Market Research Report 2022
    Published: 21-Jun-2022        Price: US 2900 Onwards        Pages: 89
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - UMF 5+ - UMF 10+ - UMF 15+ - UMF 20+ - Others Segment by Application - ......
  • Global Honey Dressings Market Research Report 2022
    Published: 21-Jun-2022        Price: US 2900 Onwards        Pages: 93
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Non-Adhesive - Adhesive Segment by Application - Ulcers - Surgical Wounds - Tr......
  • Global Osteoarthritis Drugs Market Research Report 2022
    Published: 21-Jun-2022        Price: US 2900 Onwards        Pages: 87
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Oral - Injection - External Segment by Application - Hospital Pharmacies - Ret......
  • Global Hepatic Encephalopathy Drugs Market Research Report 2022
    Published: 21-Jun-2022        Price: US 2900 Onwards        Pages: 96
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Injection - Oral Segment by Application - Hospital Pharmacies - Retail Pharmacies......
  • Global Beta-Glucan Nutraceuticals Market Research Report 2022
    Published: 21-Jun-2022        Price: US 2900 Onwards        Pages: 89
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Cereal Beta Glucan - Mushroom Beta Glucan - Yeast Beta Glucan - Others Segment by App......
  • Global Cancer Biopharmaceuticals Market Research Report 2022
    Published: 21-Jun-2022        Price: US 2900 Onwards        Pages: 98
    Cancer Biopharmaceuticals market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Cancer Biopharmaceuticals market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028. Segment by Type - Biologics - Biosimilars Segment by Application......
  • Global Non-oncology Biopharmaceuticals Market Research Report 2022
    Published: 21-Jun-2022        Price: US 2900 Onwards        Pages: 108
    Non-oncology Biopharmaceuticals market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Non-oncology Biopharmaceuticals market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028. Segment by Type - Biologics - Biosimilars Segment by App......
  • Global Pain Management Product Market Research Report 2022
    Published: 21-Jun-2022        Price: US 2900 Onwards        Pages: 109
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Opioids - Non-narcotic Analgesics Segment by Application - Hospitals - Clinics ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs